Companies / BOC Sciences / Tralokinumab
BOC Sciences

Tralokinumab | BOC Sciences

Tralokinumab is a humanized monoclonal antibody that binds to IL-13 and inhibits the interaction of IL-13 and its receptor. Tralokinumab has been used for the treatment of atopic dermatitis (AD).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.